Knothe H
Arzneimittelforschung. 1976;26(3):427-31.
The effect of pivaloyloxymethyl ester of 6-beta-[(hexahydro-1H-azepin-1-yl)-methyleneamino]-penicillanic acid (pivmecillinam, FL 1039) on the gut flora of human subjects was investigated at different doses. Following administration of 1.2 g or 2.4 g/die E. coli and other enterobacteriaceae species were markedly reduced. The response of enterococci and bacteroides species showed no uniformity. No overgrowth of the gut flora by Pseudomonas, Staphylococci or Candida was observed. Meanwhile it has been possible to inspect stool specimens of a patient who was suffering from a septicaemic Salmonella infection and was treated with a combination of pivmecillinam-HCl 4 X 800 mg/pivampicillin-HCl 4 X 350 mg/die for one month. After disappearance of Salmonellae during therapy enterobacteriaceae decreased to amounts of 10(2)--10(4), all strains of which were highly susceptible to mecillinam.
研究了6-β-[(六氢-1H-氮杂环庚烷-1-基)-亚甲基氨基]-青霉烷酸的新戊酰氧甲酯(匹美西林,FL 1039)在不同剂量下对人体肠道菌群的影响。服用1.2克/日或2.4克/日后,大肠杆菌和其他肠杆菌科菌种显著减少。肠球菌和拟杆菌属菌种的反应并不一致。未观察到假单胞菌属、葡萄球菌属或念珠菌属在肠道菌群中的过度生长。同时,对一名患有败血症性沙门氏菌感染的患者的粪便样本进行了检查,该患者接受了一个月的4×800毫克盐酸匹美西林/4×350毫克盐酸匹氨西林的联合治疗。治疗期间沙门氏菌消失后,肠杆菌科细菌数量降至10²-10⁴,所有菌株对美西林均高度敏感。